New surgical patch aims to stop bleeding faster in liver operations

NCT ID NCT05385952

Completed Disease control Sponsor: GATT Technologies BV Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new patch called GATT-Patch to see if it stops bleeding during open liver surgery better than the current patch, TachoSil. 132 adults having planned liver surgery took part. The main goal was to see if bleeding stopped within 3 minutes and did not restart.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMORRHAGE, SURGICAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Blood Loss, Surgical liver disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMORRHAGE, SURGICAL INTRAOPERATIVE BLEEDING LIVER DISEASES

Contacts and locations

Locations

Atrium Health

Charlotte, North Carolina, 28204, United States
Erasmus MC

Rotterdam, Netherlands
Heidelberg University Hospital

Heidelberg, Germany
Intermountain Healthcare

Murray, Utah, 84111, United States
Radboud University Medical Center

Nijmegen, Netherlands
Rutgers University

Newark, New Jersey, 07103, United States
University Medical Center Groningen

Groningen, Netherlands
University of Southern California

Los Angeles, California, 90033, United States
Washington University

St Louis, Missouri, 63110, United States
Weill-Cornell

New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.